D
ifficulty walking is one of the most commonly reported problems in people with multiple sclerosis (MS). 1, 2 A complex interplay of primary body structure impairments can contribute to difficulty walking, including, but not limited to, impairments in vision or oculomotor function, 3, 4 somatosensation, [5] [6] [7] tone, 8, 9 cognition, 10,11 and strength. [5] [6] [7] [8] [12] [13] [14] [15] [16] [17] [18] [19] Of modifiable impairments, muscle weakness may be a particularly important target for intervention as it is highly prevalent, 20 contributes strongly to gait, [5] [6] [7] [8] [12] [13] [14] [15] [16] [17] [18] [19] and can be widespread throughout the lower extremities and trunk even early in disability. 21 Strength training has been well studied in healthy older adults and is the single most effective exercise modality to improve gait speed in these individuals. 22 Strength training for people with MS is typically a part of a comprehensive physical therapy plan of care to improve gait, 23, 24 and guidelines exist on dosing and frequency. 24 However, while strength training has been shown to consistently improve muscle strength and endurance in people with MS, it has not consistently resulted in meaningful improvements in gait performance. [25] [26] [27] [28] [29] Possible explanations include quality of study designs, outcome measure selection, heterogeneity of protocols, dosing inconsistencies, and other causes for gait impairment besides weakness. [25] [26] [27] [28] [29] [30] An additional reason, that has received little consideration, is that intervention studies may have failed to prioritize muscles that could have the greatest effect on gait performance. 29 A number of studies have investigated the association of muscle strength to gait performance in MS. However, several gaps remain. A primary gap in knowledge is that individual studies have only examined a small number of muscle groups (maximum = 2 or 3) concurrently, making comparisons among muscle groups difficult. [5] [6] [7] [8] 12, 13, [15] [16] [17] [18] [19] 31, 32 Second, the majority of the association studies have only examined knee extension and flexion. 6, 12, [15] [16] [17] [18] [19] 31 Third, less is known about strength contributions of hip flexion and extension, and ankle plantar flexion and dorsiflexion to gait performance in people with MS. 5, 8, 7, 13 A final knowledge gap is that very little is known about the relationship of gait performance to hip abduction and trunk muscles in people with MS, 14 even though muscles of proximal stabilization are crucial to normal lower extremity movements during gait. 33 Accordingly, many of the randomized control trials of strength training to improve gait have selected knee extension and flexion as primary intervention targets and/or outcome measures, [34] [35] [36] [37] [38] [39] and few have focused on hip, ankle, or trunk muscles.
To address these gaps, this study examined the associations and relative contributions of muscle function in 11 major lower extremity and trunk muscles to gait speed and endurance in people with MS who had mild to moderate disability. The objective of the study was to determine which muscles, or combinations of muscles, had the greatest impact on gait performance. Understanding the relative contributions of lower extremity and trunk muscle function to gait performance might help to improve future intervention trial design and inform clinical decisions.
Methods

Participants
Participants were recruited at the University of Colorado Hospital Anschutz Medical Campus through the Rocky Mountain MS Center and outpatient physical therapy clinics. Prior to enrollment, all participants signed informed consent approved by the Colorado Multiple Institutional Review Board. Participants met the following eligibility criteria: 18 to 65 years old, confirmed diagnosis of MS, able to provide consent, and ambulatory for 100 meter without an assistive device or orthotic. Participants were excluded if they had pain or other conditions limiting ambulation or muscle strength, more than minimal lower extremity spasticity (≥2 on the Modified Ashworth Scale), an exacerbation or changes to drug therapy in the previous month, or were currently undergoing physical therapy for strength training.
Outcomes
The independent variables were lower extremity and trunk muscle function. In order to assess muscle function in 11 lower extremity and trunk muscles in a single session, a previously described, reliable, and valid protocol of handheld dynamometry (HHD) and muscle endurance tests was used. 21 Strength was measured by HHD (Lafayette Manual Muscle Testing System, Lafayette Instrument Co, Lafayette, Indiana) for ankle dorsiflexion; knee flexion and extension; hip flexion, extension, abduction, and adduction; and trunk lateral flexion. HHD measurements were recorded in kilograms and normalized to body mass index (BMI; kg/m 2 ). Consistent with the published protocol, 21 maximal number of heel raises was used to assess ankle plantar flexion, as HHD is likely not a valid measure of this muscle. 40 Also, commonly reported endurance measures were used in place of HHD for trunk extension (timed prone extensor endurance test), 41 and trunk flexion (maximal number of curl-ups in 1 minute). 14 The weaker side was used for all analyses, except trunk extension and flexion, which act bilaterally. If not readily apparent, the weaker side was defined by the side with weaker knee flexion. 21 The primary dependent variable was gait performance, measured by gait speed (Timed 25-Foot [7.62- 42 The average of 2 T25FW trials, reported in seconds, was used for analysis. The 6MWT measures the maximal distance in meters a person is able to walk in 6 minutes and has excellent test-retest reliability in people with MS. 43 A single trial of 6MWT was performed.
Sample Characterization
Demographic data, including age, sex, height, weight, and length of diagnosis, were collected for each participant. Disability was measured with the Expanded Disability Status Scale (EDSS). 44 A score of 0 to 3.5 was defined as mild disability, and a score of 4.0 to 5.5 was defined as moderate disability. 45 Enrollment targeted equal numbers of people in each disability group in an attempt to represent the extent of strength and gait findings in the disability range.
Procedure and Protocol
Following informed consent, demographic data were recorded. Participants then performed the T25FW twice followed by muscle assessments. EDSS assessment occurred next, followed by the 6MWT. Standardized rests of 5 minutes were provided after the T25FW, muscle testing, and EDSS assessment. The primary author collected all outcomes, had 12 years of clinical experience working with people who have MS, and completed standardized training in EDSS assessment.
Data Analysis
Regression modeling was used to quantify the associations between muscle and gait variables. Bivariate models were first constructed, and Pearson correlation coefficients (r), beta coefficients (ß), 95% CIs, and corresponding P values were reported. Beta coefficients were divided by the standard deviation for each respective variable as a method to account for differences in strength between different muscle groups, and to adjust for the different scales of measurement used to assess muscle function.
Separate multiple linear regression models for gait speed and endurance were constructed using stepwise entry, starting with the muscle with the highest significant bivariate correlation to gait as determined by the standardized beta coefficient (P < .05). A larger standardized beta would indicate that a change equivalent to 1 SD in a muscle group would correspond to a larger change in the corresponding gait measure. Following initial entry, the remaining muscle variables with significant bivariate relationships to each respective gait measure were entered into the model (P < .05) on the basis of the strength of the bivariate relationship; variables were removed in the multivariate model if the P value was ≥ .2. If 2 independent variables were correlated highly with each other (r > 0.75), only the variable with the stronger bivariate relationship to the dependent variable was considered for the multivariate model.
The multivariate model selection process was guided by a research hypothesis which stated that important contributions should be considered from each area of the body being tested. Therefore, it was determined a priori that of the 11 muscle groups, a maximum of 5 would be selected for the final regression model: 1 from the ankle (of 2), 1 from the knee (of 2), 1 from hip frontal plane (of 2), 1 from hip sagittal plane (of 2), and 1 from the trunk (of 3). Age and sex were forced into the model regardless of the P value, as these variables can affect both muscle strength and gait speed. 46, 47 A sample size of at least 70 was targeted based on the need for a minimum of 10 participants per variable for up to 7 potential candidate variables. 48 Distribution of variables and presence of outliers were assessed using a scatter plot matrix. Regression diagnostics were further analyzed to confirm that the assumptions of multiple regression were met, and to determine influence of potential outliers. Collinearity of the final model was assessed using the variance inflation factor, with values 5 or greater indicating collinearity. For the final models, beta coefficients, 95% CIs, P values, the total variance explained by the model (R 2 ), and the adjusted variance were reported. SAS (version 9.4; SAS Institute Inc, Cary, North Carolina) was used for data analysis.
Results
Seventy-two participants were enrolled, with equal numbers of participants who had mild disability (n = 36) and moderate disability (n = 36). There were 2 screen failures: 1 participant was unable to walk 100 meter unassisted, and 1 had pain that limited muscle testing. No adverse events were reported. Discomfort during strength testing was reported by 6 participants, but data were included for these participants. Fourteen participants (19%) were unable to perform any heel raises during the ankle plantar flexion test, 6 participants (8%) were unable to perform a single trunk curl-up, and 1 participant was not able to hold the trunk extension test for any time. A value of zero was recorded when the test could not be performed; no data were excluded. The sample had a mean age of 47.7 years (SD = 11.3 years) and was 83% female, and the mean EDSS score was 3.5 (SD = 1.14). There were significant differences between disability groups (P < .05) for the T25FW, the 6MWT, sex, and all muscle groups except trunk extension endurance, whereas age, BMI, and time since diagnosis were not significantly different between groups (Tab. 1).
For the T25FW, the strongest bivariate relationships were with hip abduction and knee flexion: a 1-SD increase in normalized hip abduction (0.14 kg/BMI) and knee flexion strength (0.18 kg/BMI) were each independently associated with a 0.96-second reduction in T25WT (95% CI = −1.21 to −0.72 seconds; P < .001) (Tab. 2, Fig. 1 ). The strongest bivariate relationship with 6MWT was hip abduction: a 1-SD increase in normalized hip abduction strength (0.14 kg/BMI) was independently associated with an 85.45-m increase in distance walked on the 6MWT (95% CI = 64.22 to 106.67 m; P < .001) (Tab. 2, Fig. 1 ). The remaining bivariate relationships for muscles (Tab. 2, Fig. 1 ) were significant between all strength and gait variables (P < .001-.034), except for trunk extension with T25FW (P = .085). All bivariate Pearson correlations between independent variables were significant (r = 0.23-0.81, P < .05) (Fig. 2) . Scatterplots ( Fig. 2) and regression diagnostics showed that gait and strength relationships met assumptions for linear regression, and outliers did not influence analysis and so were not excluded from analysis.
In order to construct the multivariate model for the T25FW, hip abduction and knee flexion, which had identical standardized beta coefficients and CIs, were first entered together. The selection process then considered lateral trunk flexion, followed by ankle plantar flexion, h ip flexion, adduction, and extension, and trunk flexion. For the final model, the strongest predictors of T25FW were hip abduction, knee flexion, ankle plantar flexion, and trunk flexion (Tab. 3). After adjusting for age and sex, a 1-SD increase in normalized hip abduction strength (0.14 kg/BMI) was associated with a 0.33-second reduction in the T25WT (95% CI = −0.72 to 0.07 seconds; P = .102); a 1-SD increase in normalized knee flexion strength (0.18 kg/BMI) was associated with a 0.35-second reduction in T25WT (95% CI = −0.80 to 0.04 seconds; P = .078); a 1-SD increase in ankle plantar flexion endurance (15.2 repetitions) was associated with a 0.43-second reduction in T25WT (95% CI = −0.71 to −0.14 seconds; P = .004); and a 1-SD increase in trunk flexion endurance (15.1 repetitions) was associated with a 0.23-second reduction in T25WT (95% CI = −0.47 to −0.02 seconds; P < .070) (Tab. 3).
For the 6MWT, the multivariate model started with entry of hip abduction only. The selection process then considered lateral trunk flexion, followed by hip flexion, hip adduction, ankle plantar flexion, hip extension, trunk flexion, and knee extension. In the final model, the strongest predictors of 6MWT distance were hip abduction, ankle plantar flexion, and trunk flexion (Tab. 3). After adjusting for age and sex, a 1-SD increase in normalized hip abduction strength (0.14 kg/BMI) was associated with a 54. The final model for the T25FW accounted for 57% of the adjusted variance, whereas 61% of the adjusted variance was explained for 6MWT (Tab. 3).
Variance inflation factor ranged for the final models ranged from 1.23 to 3.28 for the T25FW and from 1.23 to 1.96 for the 6MWT, indicating no collinearity for either model.
Discussion
Strength training is a common intervention in a physical therapy plan of care for people with MS, 23, 24 and along with aerobic and balance exercises, is part of recommended exercise guidelines. 24 Strength training will typically be only 1 aspect of an overall exercise program, hence it is important to prioritize strength training targets, as completing too many exercises may not be feasible for many people with MS due to commonly reported exercise participation barriers of fatigue and lack of time. 49 The current literature, however, does not provide strong evidence or rationale for which muscles to prioritize. This study found that after adjusting for age and sex, hip abduction strength, ankle plantar flexion endurance, and trunk flexion endurance were predictors of both gait speed and endurance; and knee flexion strength was also an important predictor for gait speed. These results are novel in the context of current literature on strength training, which has focused primarily on knee extension strengthening. 29, [34] [35] [36] [37] [38] [39] The failure to consider the muscles with the strongest relative contributions to gait might help explain why strengthening literature has not consistently reported meaningful improvements in gait performance. 29 The inclusion of hip abduction strength and trunk flexion endurance in the final model for both T25FW and 6MWT suggests that proximal stability in both the sagittal and frontal planes is potentially important for gait in people with MS. The relationship of hip abduction strength to gait has never been evaluated in people with MS before, though in people with post-polio syndrome 50 and cerebral palsy, 51 hip abduction strength has also been reported to be significantly associated with gait speed. Trunk flexion endurance, meanwhile, has been previously reported to be correlated with gait speed in people with MS (r = 0.68, P < .01), 14 further supporting the findings in this study. Adequate proximal control is necessary for swing limb advancement during gait; 52,53 therefore, weakness and/ or lack of endurance in these muscle groups may at least partially explain other common gait abnormalities in MS such as shorter stride length, reduced single limb support, increased double support time, and increased lateral path variability. [52] [53] [54] [55] [56] [57] [58] Of note in this study, hip abduction was the strongest predictor for the 6MWT but not the T25FW. This may be because over longer distances weakness in hip abduction leads to decreased proximal stability, whereas during short distances other muscles may be able to compensate. Recent trials have attempted to target proximal strength and endurance, primarily through Pilates-based intervention. 59, 60 These intervention studies have failed to improve gait over standard physical therapy. However, they did not measure changes in trunk or hip strength or endurance; possibly the training was not sufficiently intense. Future studies should continue to investigate the relationship of pelvic and trunk stability to gait performance in people with MS, and the efficacy of including proximal strength and endurance training to improve gait.
Ankle plantar flexion endurance was included in both final models. Ankle plantar flexion is one of the primary power generators of normal gait, as it initiates propulsion and forward advancement of the limb at push-off. 61, 62 For gait speed, ankle plantar flexion was not only the strongest predictor, but the only significant predictor after adjusting for the remaining muscles. Maximal forward propulsion from push-off in late stance is likely more important when trying to reach maximal speed on the T25FW, whereas during the 6MWT individuals might self-select a lower speed. Indeed, in this study participants walked, on average, 1.4 m/s on the T25FW compared to 1.1 m/s on the 6MWT, a difference of over 20%. Prior studies have shown that gait impairment in people with MS may be most influenced by decreased power and insufficient ankle push-off during late stance, both of which may result from ankle plantar flexion weakness. 63, 64 Although ankle plantar flexion strength was not measured due to technical limitations, the bivariate correlations between ankle plantar flexion endurance and gait performance found in the current study were similar to a prior study in people with MS between ankle plantar flexion strength and both the T25FW (r = − 0.54, P < .001) and the 6MWT (r = 0.54, P < .001). 8 Regardless of how ankle plantar flexion muscle function is assessed, it appears to have an important role in gait performance. Yet, strength or endurance training of ankle plantar flexion is rarely reported in the literature. 36, 65 Intervention studies are needed to determine if including ankle plantar flexion strength and/or endurance can improve on gait performance in people with MS.
This study found that after multivariate analysis, knee flexion remained in the final model for gait speed while knee extension did not. This is consistent with prior studies concluding that knee flexion strength may be more strongly correlated to gait speed than knee extension. 6, 12, 15, 16, 18 These results collectively support the idea that a patient with MS who is able to stand and ambulate independently (EDSS score of <6.0) may have sufficient knee extension strength, and therefore at the knee, flexion strengthening might be a more appropriate intervention to improve walking. The knee flexors are most active in normal gait during terminal swing through heel strike, 66 but in people with significant limb weakness, knee flexors may also help prevent knee hyperextension during stance. 67 People with MS have been found to have excess knee flexion in terminal swing 68 and heel strike, 57 both of which may be strategies to compensate for knee flexion weakness and avoid knee hyperextension. Knee flexion is commonly targeted in the current strengthening literature; however exercises are usually performed in a seated or prone position which is less relevant to walking. [34] [35] [36] 38, 39 Future studies might consider knee flexion strengthening in positions that are more relevant to the task of walking.
This study found that muscles not typically considered in current strength training literature might being among the most important contributors to gait performance in people with MS.
Failure to consider these muscles may partially explain the inconsistent gait outcomes in the strength training literature, and investigations are needed to determine whether interventions targeting these muscle groups improve gait outcomes. Of note, the results of this study do not suggest that interventions should exclusively target hip abduction, trunk flexion, ankle plantar flexion, and knee flexion. First, while the multivariate models explained a portion of the variance in both gait speed and endurance, other impairments can contribute to gait abnormalities. [3] [4] [5] [6] [7] [8] [9] [10] [11] Indeed, other interventions (eg, aerobic and balance training) also can improve gait. 27 Second, it is important to consider the complexity and timing of muscle activation during gait; singular strengthening of any one muscle has the potential to create asymmetries that might result in other abnormal patterns or worsen gait. Third, 10 of the 11 muscles assessed in this study had significant bivariate relationships with both gait speed and endurance suggesting that each has potentially important contributions to gait, and might be an appropriate target of strength training in an individual patient. Taken together, findings from this study support the need for more investigations into the contribution of hip abduction, knee flexion, ankle plantar flexion, and trunk flexion muscles to gait in people with MS, and provide initial support for including these muscles in strengthening programs designed to improve gait.
Limitations
A primary limitation of this study was the use of both strength and endurance assessments. The assessment protocol was chosen in part for feasibility in assessing muscle function in 11 muscles in a single session. The protocol primarily used HHD, but ankle plantar flexion, trunk extension, and trunk flexion are likely not valid when assessed by HHD, so maximal endurance measures were used instead. The use of computerized or electromechanical dynamometry would have allowed for assessment of force in every muscle, however, would not have been feasible for assessing all 11 muscles in a single session. In addition, the assessment protocol used in this study can be reproduced in the clinic, thus increasing generalizability. Nevertheless, if muscles assessed by endurance in this study had been measured by force, the results may have been different. A second limitation is that the use of maximal strength and endurance is not required for normal gait. Although this a common method used to establish correlation, future studies are needed to verify whether improving strength or endurance in these muscles can help lead to improvements in gait. Third, participants were ambulatory without assistance for at least 100 meter and had only minimal spasticity. These exclusion criteria allowed for a direct strength to gait comparison (without the confounding elements of an orthotic, assistive device, or severe spasticity), yet limit generalizability. Finally, only gait speed and endurance were assessed, and different muscles might be important for other functional activities (eg, stair climbing, sit to stand, dynamic gait activities).
Conclusions
Hip abduction strength, ankle plantar flexion endurance, and trunk flexion endurance explained a substantial amount of variance for both gait speed and endurance in people with MS with mild to moderate disability; and knee flexion strength explained additional variance in gait speed only. These findings support consideration of these muscles when designing strength interventions to improve gait, though future trials are needed to determine if strengthening that includes these muscles can help to improve gait in people with MS.
